Rahul Datta, MD, PhD
Assistant Professor of Clinical Pediatrics (Allergy/Immunology)
Attending Physician, Division of Allergy & Immunology, Children's Hospital of Philadelphia
Epic Champion, Division of Allergy & Immunology, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Buerger Building
3500 Civic Center Blvd
Philadelphia, PA
Buerger Building
3500 Civic Center Blvd
Philadelphia, PA
Education:
BS (Biology)
University of North Carolina, Chapel Hill, 2002.
PhD
Louisiana State University Health Sciences Center, 2010.
MD
Louisiana State University Health Sciences Center , 2012.
Permanent linkBS (Biology)
University of North Carolina, Chapel Hill, 2002.
PhD
Louisiana State University Health Sciences Center, 2010.
MD
Louisiana State University Health Sciences Center , 2012.
Selected Publications
Kim Nguyen, Megan O Lewis, Elizabeth Hanna, Maria Katerina C Alfaro, Kristen Corrigan, Jillian Buonanno, Rahul Datta, Terri Brown-Whitehorn, Jonathan M Spergel, Antonella Cianferoni.: Safety of multi-food oral immunotherapy in children aged 1-18 years at an academic pediatric clinic. The Journal of Allergy and Clinical Immunology: In Practice 11(6): 1907-1913, Jun 2023.Rahul Datta: Determining candidates for peanut oral immunotherapy: Insights from the RAMSES trial. Ann Allergy Asthma Immunol 129(6): 661-662, December 2022.
Rahul Datta MD, PhD, Stacie Jones MD: Cracking the Nut: Oral Immunotherapy Conundrums. The Journal of Allergy and Clinical Immunology: In Practice 10(6): 1664-1665, Jun 2022.
Stanislaw J. Gabryszewski MD, PhD Rahul Datta MD, PhD: Allergy and Immunology | Allergic Rhinitis. Netter's Pediatrics, 2e, 2022 Notes: Section 4.
Datta R, Kuruvilla M, Gill M, de la Morena MT.: Association of skin necrosis with subcutaneous immunoglobulin therapy. Ann Allergy Asthma Immunol. 113(2): 232-3, July 2014.
Datta R, Naura AS, Zerfaoui M, Errami Y, Oumouna M, Kim H, Ju J, Ronchi VP, Haas AL, Boulares AH.: PARP-1 deficiency blocks IL-5 expression through calpain-dependent degradation of STAT-6 in a murine asthma model. Allergy 66(7): 853-61, July 2011.
Naura AS, Datta R, Hans CP, Zerfaoui M, Rezk BM, Errami Y, Oumouna M, Matrougui K, Boulares AH.: Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia. Eur Respir J. 33(2): 252-62, February 2009.
Oumouna-Benachour K, Hans CP, Suzuki Y, Naura A, Datta R, Belmadani S, Fallon K, Woods C, Boulares AH.: Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death. Circulation. 115(18): 2442-50, May 2007.
Oumouna M, Datta R, Oumouna-Benachour K, Suzuki Y, Hans C, Matthews K, Fallon K, Boulares H.: Poly(ADP-ribose) polymerase-1 inhibition prevents eosinophil recruitment by modulating Th2 cytokines in a murine model of allergic airway inflammation: a potential specific effect on IL-5. J Immunol. 177(9): 6489-96, November 2006.